Loading company…
VenuSilk develops injectable silk fibroin gel products for medical aesthetics.
Founded in 2025 and based in Suzhou, China, VenuSilk researches and develops medical aesthetic products. Its injectable silk fibroin gels are designed to support skin and promote collagen regeneration. The company raised angel funding from Hanchi Venture in March 2025 and pre-Series A funding led by Huaige Capital in October 2025, with Hanchi Venture participating again.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in